Proficio Capital Partners’s Corcept Therapeutics CORT Stock Holding History

Proficio Capital Partners’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-30	Closed	–	–	1963
2019 Q1	$0	Buy	+30	New	+$373	﹤0.01%	1693

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Proficio Capital Partners's CORT Position: Q2 2019 in Review

Proficio Capital Partners sold out of Corcept Therapeutics (CORT) in Q2 2019, closing a stake of 30 shares.

Proficio Capital Partners first reported a position in CORT in Q1 2019 and held it in 1 quarter. The position peaked at $0 in Q1 2019. 183 funds tracked by Wall St. Rank hold CORT as of Q2 2019.

Proficio Capital Partners reported no remaining Corcept Therapeutics position as of Q2 2019 after selling out during the quarter.
Proficio Capital Partners sold 30 Corcept Therapeutics shares in Q2 2019.
Proficio Capital Partners first reported a position in Corcept Therapeutics in Q1 2019 and held it in 1 quarter.
Proficio Capital Partners's Corcept Therapeutics position peaked at $0 in Q1 2019.
183 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2019.

Based on Proficio Capital Partners's 13F filing for Q2 2019, filed 13 Aug 2019.